Evidence-based prevention and treatment of dementia
[...]it went on to note that "a public health perspective should be systematised and viewed as a core principle in efforts to defeat AD and other dementias, rather than playing second fiddle to the search for a magic-bullet therapy".1 In the absence of such a therapy, the focus must remain...
Gespeichert in:
Veröffentlicht in: | Lancet neurology 2016-09, Vol.15 (10), p.1006-1007 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1007 |
---|---|
container_issue | 10 |
container_start_page | 1006 |
container_title | Lancet neurology |
container_volume | 15 |
creator | Glynn, Ronan W Dolan, Catherine Shelley, Emer Lawlor, Brian |
description | [...]it went on to note that "a public health perspective should be systematised and viewed as a core principle in efforts to defeat AD and other dementias, rather than playing second fiddle to the search for a magic-bullet therapy".1 In the absence of such a therapy, the focus must remain on prevention across the life course, with an emphasis on public health interventions that aim both to prevent the exposure to or the development of risk factors and to reduce risk in those who already have several established risk factors for dementia. |
doi_str_mv | 10.1016/S1474-4422(16)30122-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1815681885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1474442216301223</els_id><sourcerecordid>1815681885</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-6dd57a1a9d82db10c39d801878c8bf1daee24e403df6d698aee82743fd9e3d213</originalsourceid><addsrcrecordid>eNqFkE1LJDEQhoO4-P0TlAYv7qF3U0k6nbkoy6DugrAH9RwyqWqI9nSPSc-A_970zKjgxVMqxVNvKg9jp8B_AQf9-x5UrUqlhLgA_VNyEKKUO-xg29bV7kctxD47TOmJcwHKwB7bF7WquKr5AZPXq4DUeSpnLhEWi0gr6obQd4XrsBgiuWGeG0XfFEhjFdwx-9G4NtHJ9jxijzfXD9O_5d3_23_TP3ellxM9lBqxqh24CRqBM-C5i4aDqY03swbQEQlFiktsNOqJyXeTF5MNTkiiAHnELja5i9i_LCkNdh6Sp7Z1HfXLZMFApQ0YU2X0_Av61C9jl7cbKeCq0lJlqtpQPvYpRWrsIoa5i68WuB2t2rVVOyqz-ba2amWeO9umL2dzwo-pd40ZuNoAlHWsAkWbfBitYojkB4t9-PaJyy8Jvg1d8K59pldKn7-xSVi-CRkzQK8TpHwDts-Z1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1811045634</pqid></control><display><type>article</type><title>Evidence-based prevention and treatment of dementia</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Glynn, Ronan W ; Dolan, Catherine ; Shelley, Emer ; Lawlor, Brian</creator><creatorcontrib>Glynn, Ronan W ; Dolan, Catherine ; Shelley, Emer ; Lawlor, Brian</creatorcontrib><description>[...]it went on to note that "a public health perspective should be systematised and viewed as a core principle in efforts to defeat AD and other dementias, rather than playing second fiddle to the search for a magic-bullet therapy".1 In the absence of such a therapy, the focus must remain on prevention across the life course, with an emphasis on public health interventions that aim both to prevent the exposure to or the development of risk factors and to reduce risk in those who already have several established risk factors for dementia.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(16)30122-3</identifier><identifier>PMID: 27450470</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alzheimer's disease ; Dementia ; Health care ; Humans ; Neurology ; Public health ; Risk Factors</subject><ispartof>Lancet neurology, 2016-09, Vol.15 (10), p.1006-1007</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Sep 01, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c396t-6dd57a1a9d82db10c39d801878c8bf1daee24e403df6d698aee82743fd9e3d213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1811045634?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994,64384,64386,64388,72240</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27450470$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glynn, Ronan W</creatorcontrib><creatorcontrib>Dolan, Catherine</creatorcontrib><creatorcontrib>Shelley, Emer</creatorcontrib><creatorcontrib>Lawlor, Brian</creatorcontrib><title>Evidence-based prevention and treatment of dementia</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>[...]it went on to note that "a public health perspective should be systematised and viewed as a core principle in efforts to defeat AD and other dementias, rather than playing second fiddle to the search for a magic-bullet therapy".1 In the absence of such a therapy, the focus must remain on prevention across the life course, with an emphasis on public health interventions that aim both to prevent the exposure to or the development of risk factors and to reduce risk in those who already have several established risk factors for dementia.</description><subject>Alzheimer's disease</subject><subject>Dementia</subject><subject>Health care</subject><subject>Humans</subject><subject>Neurology</subject><subject>Public health</subject><subject>Risk Factors</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkE1LJDEQhoO4-P0TlAYv7qF3U0k6nbkoy6DugrAH9RwyqWqI9nSPSc-A_970zKjgxVMqxVNvKg9jp8B_AQf9-x5UrUqlhLgA_VNyEKKUO-xg29bV7kctxD47TOmJcwHKwB7bF7WquKr5AZPXq4DUeSpnLhEWi0gr6obQd4XrsBgiuWGeG0XfFEhjFdwx-9G4NtHJ9jxijzfXD9O_5d3_23_TP3ellxM9lBqxqh24CRqBM-C5i4aDqY03swbQEQlFiktsNOqJyXeTF5MNTkiiAHnELja5i9i_LCkNdh6Sp7Z1HfXLZMFApQ0YU2X0_Av61C9jl7cbKeCq0lJlqtpQPvYpRWrsIoa5i68WuB2t2rVVOyqz-ba2amWeO9umL2dzwo-pd40ZuNoAlHWsAkWbfBitYojkB4t9-PaJyy8Jvg1d8K59pldKn7-xSVi-CRkzQK8TpHwDts-Z1Q</recordid><startdate>20160901</startdate><enddate>20160901</enddate><creator>Glynn, Ronan W</creator><creator>Dolan, Catherine</creator><creator>Shelley, Emer</creator><creator>Lawlor, Brian</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20160901</creationdate><title>Evidence-based prevention and treatment of dementia</title><author>Glynn, Ronan W ; Dolan, Catherine ; Shelley, Emer ; Lawlor, Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-6dd57a1a9d82db10c39d801878c8bf1daee24e403df6d698aee82743fd9e3d213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Alzheimer's disease</topic><topic>Dementia</topic><topic>Health care</topic><topic>Humans</topic><topic>Neurology</topic><topic>Public health</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glynn, Ronan W</creatorcontrib><creatorcontrib>Dolan, Catherine</creatorcontrib><creatorcontrib>Shelley, Emer</creatorcontrib><creatorcontrib>Lawlor, Brian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glynn, Ronan W</au><au>Dolan, Catherine</au><au>Shelley, Emer</au><au>Lawlor, Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidence-based prevention and treatment of dementia</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2016-09-01</date><risdate>2016</risdate><volume>15</volume><issue>10</issue><spage>1006</spage><epage>1007</epage><pages>1006-1007</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><coden>LANCAO</coden><abstract>[...]it went on to note that "a public health perspective should be systematised and viewed as a core principle in efforts to defeat AD and other dementias, rather than playing second fiddle to the search for a magic-bullet therapy".1 In the absence of such a therapy, the focus must remain on prevention across the life course, with an emphasis on public health interventions that aim both to prevent the exposure to or the development of risk factors and to reduce risk in those who already have several established risk factors for dementia.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27450470</pmid><doi>10.1016/S1474-4422(16)30122-3</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1474-4422 |
ispartof | Lancet neurology, 2016-09, Vol.15 (10), p.1006-1007 |
issn | 1474-4422 1474-4465 |
language | eng |
recordid | cdi_proquest_miscellaneous_1815681885 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland |
subjects | Alzheimer's disease Dementia Health care Humans Neurology Public health Risk Factors |
title | Evidence-based prevention and treatment of dementia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T09%3A32%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidence-based%20prevention%20and%20treatment%20of%20dementia&rft.jtitle=Lancet%20neurology&rft.au=Glynn,%20Ronan%20W&rft.date=2016-09-01&rft.volume=15&rft.issue=10&rft.spage=1006&rft.epage=1007&rft.pages=1006-1007&rft.issn=1474-4422&rft.eissn=1474-4465&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1474-4422(16)30122-3&rft_dat=%3Cproquest_cross%3E1815681885%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1811045634&rft_id=info:pmid/27450470&rft_els_id=1_s2_0_S1474442216301223&rfr_iscdi=true |